Differential effects of C5a on human and mouse mast cells may be mediated by C5aR and C5L2 by Pundir, P et al.
POSTER PRESENTATION Open Access
Differential effects of C5a on human and mouse
mast cells may be mediated by C5aR and C5L2
P Pundir
1,2*, CH Sheen
3, A Catalli
1, V Karpov
1, K Cianflone
4, M Kulka
1,2,3
From Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2009
Halifax, Canada. 22-25 October 2009
Rationale
The complement anaphylatoxin 5a (C5a) is an inflam-
matory mediator associated with the pathology of
inflammatory diseases such as sepsis. C5a mediates its
pro-inflammatory effects via interaction with two C5a
receptors, C5aR and C5L2. C5aR initiates G protein-
coupled receptor signaling while C5L2 is not coupled to
G proteins and its role in C5a-mediated immune pro-
cesses is not well understood. We hypothesized that
mast cells (MC) expressed C5aR and/or C5L2 and that
C5a activated MC through these receptors.
Methods
Human MC (LAD2) and bone marrow-derived MC
(BMMC) were stimulated with C5a and degranulation
was determined by measurement of b-hexosaminidase
release. BMMC were cultured from bone marrow of
wild type and CL52 knock-out mice in interleukin-4
(300U/ml) and stem cell factor (50ng/ml). Tumor necro-
sis factor (TNF), granulocyte macrophage colony-stimu-
lating factor (GM-CSF), monocyte chemotactic protein-
1 (MCP-1) and interferon-inducible protein-10 (IP-10)
production was measured by cytometric bead array.
Expression of C5aR and C5L2 receptors was analyzed by
quantitative PCR (qPCR) and flow cytometry.
Results
C5a (100ng/ml) stimulated LAD2 degranulation (25%) and
production of TNF (22±1.3pg/ml), GM-CSF (15±0.4pg/
ml), MCP-1 (53±3.6pg/ml) and IP-10 (32±4.3pg/ml).
qPCR showed that LAD2 expressed mRNA for C5a and
C5L2 and flow cytometry showed that LAD2 expressed
surface C5L2 but not C5aR. BMMC from wild type mice
expressed both C5aR and C5L2 but did not degranulate in
response to C5a. However, BMMC from C5L2 knock-out
mice expressed C5aR but not C5L2 and degranulated
(14.5±0.8%).
Conclusions
LAD2 express C5L2 but not C5aR and respond to C5a
by releasing granule contents, cytokines and chemokines
suggesting that C5L2 is an excitatory receptor in human
MC. BMMC expressing C5aR but lacking C5L2 degra-
nulate in response to C5a suggesting that C5L2 may
function as a decoy receptor in mouse MC. These data
show the potential importance and complexity of C5a
and its two receptors in immune responses.
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